Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • Bitcoin CAD

    87,641.02
    +320.70 (+0.37%)
     
  • CMC Crypto 200

    1,366.99
    +54.36 (+4.14%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Company News For Oct 18, 2017

SNE vs. DLB: Which Stock Is the Better Value Option?
  • Shares of Morgan Stanley MS surged 0.4% after the company posted third quarter 2017 earnings per share of $0.93, beating the Zacks Consensus Estimate of $0.81

  • Charles Schwab Corp.’s SCHW shares plummeted 2.4% after posting third quarter 2017 revenues of $2,165 million, below the Zacks Consensus Estimate of $2,184 million

  • Shares of Hancock Holding Company HBHC declined 1.4% after posting third quarter 2017 revenues of $270 million, below the Zacks Consensus Estimate of $280 million

  • Fulton Financial Corp.’s FULT shares declined 1.6% after posting third quarter 2017 earnings per share of $199 million, below the Zacks Consensus Estimate of $203 million


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Fulton Financial Corporation (FULT) : Free Stock Analysis Report
 
Hancock Holding Company (HBHC) : Free Stock Analysis Report
 
Morgan Stanley (MS) : Free Stock Analysis Report
 
The Charles Schwab Corporation (SCHW) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research